Sea Crest Wealth Management, LLC Tandem Diabetes Care Inc Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$53.22 - $123.09 $59,872 - $138,476	1,125 New	1,125 $67,000
Q2 2019 Jul 19, 2019	SELL	$54.41 - $71.7 $32,645 - $43,020	-600 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$32.25 - $73.56 $16,125 - $36,780	500 Added 500.0%	600 $38,000
Q4 2018 Feb 13, 2019	SELL	$28.45 - $40.65 $14,225 - $20,325	-500 Reduced 83.33%	100 $4,000
Q2 2018 Aug 03, 2018	BUY	$4.9 - $23.64 $2,940 - $14,184	600 New	600 $13,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.